Chien-Li Holmes-Liew
Overview
Explore the profile of Chien-Li Holmes-Liew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Brown Z, Holmes-Liew C, Chapman S, Glanville A, Limaye V
Intern Med J
. 2019 Dec;
49(12):1549-1550.
PMID: 31808258
No abstract available.
12.
Visser S, Bye P, Fox G, Burr L, Chang A, Holmes-Liew C, et al.
Lung
. 2019 Nov;
197(6):803-810.
PMID: 31691027
Purpose: Australian data regarding the management of patients with bronchiectasis is scarce. We sought to compare the management of adults with bronchiectasis attending tertiary Australian centres with recent national and...
13.
Hodge G, Hodge S, Liu H, Nguyen P, Holmes-Liew C, Holmes M
Transplantation
. 2019 Oct;
103(11):2255-2263.
PMID: 31651733
Background: Immunosuppression therapy is ineffective at preventing chronic rejection of lung allografts (bronchiolitis obliterans syndrome [BOS]) and proinflammatory cytokines by steroid-resistant lymphocytes. The class III NAD-sirtuin 1 (SIRT1) is an...
14.
Visser S, Bye P, Fox G, Burr L, Chang A, Holmes-Liew C, et al.
Respir Med
. 2019 Jul;
155:97-103.
PMID: 31326739
Background: /objective: There are no large, multi-centre studies of Australians with bronchiectasis. The Australian Bronchiectasis Registry (ABR) was established in 2015 to create a longitudinal research platform. We aimed to...
15.
Law N, Hamandi B, Fegbeutel C, Silveira F, Verschuuren E, Ussetti P, et al.
J Heart Lung Transplant
. 2019 Jul;
38(9):963-971.
PMID: 31300191
Background: Bronchiolitis obliterans syndrome (BOS) is a major limitation in the long-term survival of lung transplant recipients (LTRs). However, the risk factors in the development of BOS remain undetermined. We...
16.
Crowhurst T, Lightfoot J, Yeo A, Reddi B, Nguyen P, Whitford H, et al.
BMC Pulm Med
. 2019 Jul;
19(1):119.
PMID: 31266473
Background: There are few cases of multiple bronchial stenoses reported in the literature and none of the severity described here. The case is relevant due to its rareness, the pathophysiological...
17.
Smith C, Beagley L, Rehan S, Neller M, Crooks P, Solomon M, et al.
Clin Infect Dis
. 2018 Jul;
68(4):632-640.
PMID: 29982441
Background: Opportunistic infections including cytomegalovirus (CMV) are a major cause of morbidity and mortality in solid organ transplant (SOT) recipients. The recurrent and protracted use of antiviral drugs with eventual...
18.
Hodge G, Hodge S, Yeo A, Nguyen P, Hopkins E, Holmes-Liew C, et al.
Transplantation
. 2017 Sep;
101(10):2469-2476.
PMID: 28926522
Background: Immunosuppression therapy after lung transplantation fails to prevent bronchiolitis obliterans syndrome (BOS) in many patients, primarily a disease of the small airways. We have reported that BOS is associated...
19.
Hodge G, Hodge S, Holmes-Liew C, Reynolds P, Holmes M
Respirology
. 2017 Jan;
22(2):394-400.
PMID: 28102966
Background And Objective: Immunosuppression therapy following lung transplantation fails to prevent chronic rejection in many patients, which is associated with lack of suppression of cytotoxic mediators and pro-inflammatory cytokines in...
20.
Holmes-Liew C, Holmes M, Beagley L, Hopkins P, Chambers D, Smith C, et al.
Clin Transl Immunology
. 2015 Apr;
4(3):e35.
PMID: 25859390
Infections with cytomegalovirus (CMV) can induce severe complications after solid organ transplantation (SOT). The prognosis for ganciclovir-resistant CMV infection and disease is particularly poor. Whereas adoptive transfer of CMV-specific T...